United States DC Circuit
PHARMACHEMIE, B.V. v. BARR LABS., INC., 00-5206, 00-5207
Drug licensee seeking to appeal an Abbreviated New Drug Application decision for marketing a generic drug before the expiration of a patent has a moot appeal if another district court holds that no one can market the generic drug until the expiration of the underlying patent.
Appellate Information
- Argued 12/05/2001
- Decided 01/18/2002
- Published 01/18/2002
Judges
- Before: SENTELLE and ROGERS, Circuit Judges, and WILLIAMS, Senior Circuit Judge.
Court
- United States DC Circuit
Counsel
- For Appellant:
- James F. Hurst argued the cause for appellant. With him on the briefs was Christine J. Siwik.
- For Appellees:
- John F. Cooney argued the cause and filed the brief for appellee.